drugset / Trial / NCT05340725
Rectal Dexmedetomidine Niosomes for Postoperative Analgesia in Pediatric Cancer Patients.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Applying nanotechnology in drug delivery systems improved the bioavailability and kinetic profile of drugs in biological systems
Timeline
- Start
- 2022-05-01
- Primary completion
- 2023-12-01
- Completion
- 2023-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 1 ug/kg | Intravenous |
Indications
No indication recorded.